COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,620 Articles (22,913 medRxiv, 8,707 bioRxiv)

Most recent first Previous |  Page 835: Articles 8341-8350  | Next

Population-based Oral Cancer Service Screening Disrupted by COVID-19 Pandemic: Observational and Simulation Study
Su, C.-W., Liu, Y.-T., Yen, A. M.-F., Chiu, H.-M., Chen, T. H.-H., Hsu, T.-H., Shih, M.-Y., Su, W. W.-Y., Chen, S. L.-S.
10.1101/2022.05.03.22274618 — Posted: 2022-05-03
SARS-CoV-2 outbreaks in secondary school settings in the Netherlands during fall 2020; silent circulation
Jonker, L., Linde, K. J., de Hoog, M. L., Sprado, R., Huisman, R., Molenkamp, R., Oude Munnink, B. B., Dohmen, W., Heederik, D. J., Eggink, D., Welkers, M. R., Vennema, H., Koopmans, M. P., Fraaij, P. L., Wouters, I. M., Bruijning-Verhagen, P. C.
10.1101/2022.05.02.22273861 — Posted: 2022-05-03
Kidney Transplant Recipients and Omicron: Outcomes, effect of vaccines and the efficacy and safety of novel treatments
Gleeson, S., Martin, P., Thomson, T., Thind, A., Prendecki, M., Spensley, K. J., Clarke, C., Roufosse, C., Pickard, G., Thomas, D., McAdoo, S. P., Lightstone, L., Kelleher, P., Willicombe, M.
10.1101/2022.05.03.22274524 — Posted: 2022-05-03
An Early Return-to-Work Program for COVID-19 Close Contacts in Healthcare During the Omicron Wave in Japan
Naruse, H., Doi, Y., Iwata, M., Ishikawa, K.
10.1101/2022.05.02.22274478 — Posted: 2022-05-03
Immunogenicity and reactogenicity of a third dose of BNT162b2 vaccine for COVID-19 after a primary regimen with BBIBP-CorV or BNT162b2 vaccines in Lima, Peru.
Vargas Herrera, N. G., Fernandez-Navarro, M., Cabezudo-Pillpe, N., Soto-Becerra, P., Solis-Sanchez, G., Escobar-Agreda, S., Silva-Valencia, J., Pampa-Espinoza, L., Bado-Perez, R., Solari, L., Araujo-Castillo, R. V.
10.1101/2022.05.01.22274548 — Posted: 2022-05-03
SOFA score performs worse than age for predicting mortality in patients with COVID-19
Sherak, R. A. G., Sajjadi, H., Khimani, N., Tolchin, B., Jubanyik, K., Taylor, R. A., Schulz, W., Mortazavi, B. J., Haimovich, A. D.
10.1101/2022.05.02.22274575 — Posted: 2022-05-03
Comparative analysis of the outcomes of COVID-19 between patients infected with SARS-CoV-2 Omicron and Delta variants: a retrospective cohort study
Gunadi, , Hakim, M. S., Wibawa, H., Vujira, K., Puspitarani, D. A., Supriyati, E., Trisnawati, I., Iskandar, K., Khair, R. E., Afiahayati, , Siswanto, , Puspadewi, Y., Irene, , Irianingsih, S. H., Daniwijaya, E. W., Nugrahaningsih, D. A. A., Gabriela, G. C., Geometri, E. T., Eryvinka, L. S., Utami, F. D. T., Devana, E. M., Aditama, L., Kinasih, N. C. P., Amadeus, V. C., Hediningsih, Y., Ananda, N. R., Arguni, E., Nuryastuti, T., Wibawa, T.
10.1101/2022.04.30.22274532 — Posted: 2022-05-03
Describing COVID-19 Patients During The First Two Months of Paxlovid (Nirmatrelvir/Ritonavir) Initiation in a Large HMO in Israel
Tene, L., Chodick, G., Fallach, N., Ansari, W., Distelman-Menachem, T., Maor, Y.
10.1101/2022.05.02.22274586 — Posted: 2022-05-03
Continued Emergence and Evolution of Omicron in South Africa: New BA.4 and BA.5 lineages
Tegally, H., Moir, M., Everatt, J., Giovanetti, M., Scheepers, C., Wilkinson, E., Subramoney, K., Moyo, S., Amoako, D. G., Althaus, C. L., Anyaneji, U. J., Kekana, D., Viana, R., Giandhari, J., Maponga, T. G., Maruapula, D., Choga, W., Mayaphi, S. H., Mbhele, N., Gaseitsiwe, S., Msomi, N., Naidoo, Y., Pillay, S., Sanko, T. a., San, J. E., Scott, L., Singh, L., Magini, N. A., Smith-Lawrence, P., Stevens, W. S., Dor, G., Tshiabuila, D., Wolter, N., Preiser, W., Treurnicht, F. K., Venter, M., Davids, M., Chiloane, G., Mendes, A., McIntyre, C., O'Toole, A., Ruis, C., Peacock, T. P., Roemer, C., Williamson, C., Pybus, O. G., Bhiman, J. N., Glass, A. J., Martin, D. P., Rambaut, A., Gaseitsiwe, S., von Gottberg, A., Baxter, C., Lessells, R. J., de Oliveira, T.
10.1101/2022.05.01.22274406 — Posted: 2022-05-02
Omicron infection induces low-level, narrow-range SARS-CoV-2 neutralizing activity
Turelli, P., Zaballa, M. E., Raclot, C., Fenwick, C., Kaiser, L., Eckerle, I., Pantaleo, G., Guessous, I., Stringhini, S., Trono, D.
10.1101/2022.05.02.22274436 — Posted: 2022-05-02

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).